R&D Systems™ Recombinant Human Neuropilin-1 Fc Chimera Protein

Catalog No.	Quantity
10455N1050	50 μg

Catalog No. 10455N1050 Supplier R&D Systems™ Supplier No. 10455N1050

Description

Measured by its binding ability in a functional ELISA. When Recombinant Human Neuripilin-1 Fc Chimera is immobilized at 1 μg/mL (100 μL/well), Recombinant Human VEGF 165 (Catalog # 293-VE ) binds with an ED50 of 0.25-1.5 ng/mL.

Specifications

• Accession Number: NP_003864.4
• For Use With (Application): Bioactivity
• Formulation: Lyophilized from a 0.2 μm filtered solution in PBS.
• Gene ID (Entrez): 8829
• Molecular Weight (g/mol): M.W.-observed: 117-131 kDa, under reducing conditions, M.W.-theroretical: 120 kDa
• Quantity: 50 μg
• Source: Human embryonic kidney cell, HEK293-derived human Neuropilin-1 protein Human Neuropilin-1 (Phe22-Lys852) (N-terminus) Accession # NP_003864.4 IEGRMD Human IgG1 (Pro100-Lys330) (C-terminus)
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, -20°C to -70°C under sterile conditions after reconstitution.
• Endotoxin Concentration: <0.10 EU / 1 μg of the protein by the LAL method.
• Gene Alias: BDCA4, BDCA-4, CD304, CD304 antigen, DKFZp686A03134, DKFZp781F1414, neuropilin 1, neuropilin-1, Neuropilin1, NP1, NRP, NRP1, transmembrane receptor, Vascular endothelial cell growth factor 165 receptor, VEGF165R
• Conjugate: Unconjugated
• Reconstitution: Reconstitute at 500 μg/mL in PBS.
• Purity or Quality Grade: >95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining.
• Protein: Neuropilin-1